— Know what they know.
Not Investment Advice
Also trades as: DHR-PA (NYSE) · $vol 45M · DHR-PB (NYSE) · $vol 16M · 0R2B.L (LSE) · $vol 2M · DAP.DE (XETRA) · $vol 0M

DHR NYSE

Danaher Corporation
1W: +3.8% 1M: +4.0% 3M: +17.2% YTD: +1.7% 1Y: +5.4% 3Y: +14.4% 5Y: -11.4%
$232.09
-0.88 (-0.38%)
After Hours: $232.00 (-0.09, -0.04%)
Weekly Expected Move ±4.7%
$209 $220 $230 $241 $252
NYSE · Healthcare · Medical - Diagnostics & Research · Tech Score Strong Buy · Power 71 · $163.8B mcap · 626M float · 0.757% daily turnover · Short 42% of daily vol
Credit Risk of going bust: lower than 77% of companies Debt: 13.9% of company value Bonds: $108.9M held by 148 funds, 71 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $2.66 (down 99%), Danaher Corporation would be worth roughly what it owes.
Total debt $26.48B against a stock market value of $163.77B.
Distance to default 9.04 (Merton model): prices to 2026-10-26, balance sheet 2026-09-25, debt counted $14.29B (short-term plus half of long-term), stock volatility 30.2%; Altman Z'' 3.91. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Smart Money Score
Bullish 75
Insider—
Congress11 trades
ETF Holdings—
Key Statistics
Market Cap$163.8B
52W Range160.93-242.8
Volume3,120,886
Avg Volume4,739,914
Beta0.80
Dividend$1.44
Analyst Ratings
31 Buy 11 Hold 1 Sell
Consensus Buy
Company Info
CEOJulie Sawyer Montgomery
Employees59,000
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1978-12-29
2200 Pennsylvania Avenue, NW
Washington, DC 20037-1701
US
202 828 0850
About Danaher Corporation

Danaher Corporation is a diversified global technology and science company that specializes in developing, manufacturing, and distributing a wide array of professional, medical, industrial, and commercial products and services across the world. The organization is structured into three primary operating segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Within the Life Sciences segment, Danaher provides advanced instrumentation and solutions crucial for scientific research and development. This encompasses equipment like mass spectrometers, flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization tools, and microscopes, alongside genomics consumables and technologies vital for Gene and Cell Therapy. Additionally, it delivers bioprocess technologies, consumables, and related services, as well as sophisticated filtration, separation, and purification systems. Its diverse clientele includes pharmaceutical, biopharmaceutical, food and beverage, medical, and life sciences companies, in addition to universities, medical schools, research institutions, and various industrial manufacturers. The Diagnostics segment is dedicated to furnishing essential tools for healthcare. Its offerings range from comprehensive systems for chemistry, immunoassay, microbiology, and automation to products for hematology, molecular, acute care, and pathology diagnostics. This segment equips hospitals, physicians' offices, reference laboratories, and other critical care settings with clinical instruments, reagents, consumables, software, and support services for accurate patient diagnosis and management. The Environmental & Applied Solutions segment addresses a broad spectrum of industrial and resource management requirements. It supplies instrumentation, consumables, software, services, and disinfection systems critical for the analysis, treatment, and management of various water types—including ultra-pure, potable, industrial, waste, ground, source, and ocean water—across residential, commercial, industrial, and natural resource applications. Furthermore, this segment delivers instruments, software, services, and consumables tailored for color and appearance management, packaging design and quality assurance, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. Established in 1969, the company was initially known as Diversified Mortgage Investors, Inc., before officially rebranding as Danaher Corporation in 1984. Its corporate headquarters are located in Washington, D.C.

Recent Insider Trades

NameTypeSharesPriceDate
COMAS DANIEL L 0 — 2026-10-09
COMAS DANIEL L 0 — 2026-10-09
COMAS DANIEL L 0 — 2026-10-09
COMAS DANIEL L 0 — 2026-10-09
COMAS DANIEL L 52,338 — 2026-10-09

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms